AF
BIB icon

Allworth Financial’s ProShares Ultra NASDAQ Biotechnology BIB Stock Holding History

Allworth Financial’s Portfolio BIB Stock Details BIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-40
Closed -$2K – 2669
2022
Q2 		$2K Hold
40
– – ﹤0.01% 1985
2022
Q1 		$2K Hold
40
– – ﹤0.01% 1773
2021
Q4 		$3K Hold
40
– – ﹤0.01% 1632
2021
Q3 		$4K Hold
40
– – ﹤0.01% 1552
2021
Q2 		$4K Hold
40
– – ﹤0.01% 1240
2021
Q1 		$3K Hold
40
– – ﹤0.01% 1218
2020
Q4 		$3K Hold
40
– – ﹤0.01% 1066
2020
Q3 		$3K Buy
+40
New +$2.84K ﹤0.01% 909

Other funds holding BIB

Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
CIA
Capital Investment Advisors Atlanta, Georgia $6.84B AUM 17.28% 1-Year Est. Return
TFA
Toth Financial Advisory Leesburg, Virginia $1.02B AUM 28.36% 1-Year Est. Return
Simplex Trading
Simplex Trading Chicago, Illinois $149B AUM 62.07% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
CG
Cutler Group San Francisco, California $307M AUM 45.11% 1-Year Est. Return
US Bancorp
US Bancorp Minneapolis, Minnesota $82.4B AUM 19.69% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return

Allworth Financial's BIB Position: Q3 2022 in Review

Allworth Financial sold out of ProShares Ultra NASDAQ Biotechnology (BIB) in Q3 2022, closing a stake of 40 shares — an estimated $2K sold.

Allworth Financial first reported a position in BIB in Q3 2020 and held it in 8 quarters. The position peaked at $4K in Q3 2021. 19 funds tracked by Wall St. Rank hold BIB as of Q3 2022.

  • Allworth Financial reported no remaining ProShares Ultra NASDAQ Biotechnology position as of Q3 2022 after selling out during the quarter.
  • Allworth Financial sold 40 ProShares Ultra NASDAQ Biotechnology shares in Q3 2022, an estimated $2K.
  • Allworth Financial first reported a position in ProShares Ultra NASDAQ Biotechnology in Q3 2020 and held it in 8 quarters.
  • Allworth Financial's ProShares Ultra NASDAQ Biotechnology position peaked at $4K in Q3 2021.
  • 19 funds tracked by Wall St. Rank held ProShares Ultra NASDAQ Biotechnology as of Q3 2022.

Based on Allworth Financial's 13F filing for Q3 2022, filed 18 Oct 2022.